Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix granted inducement equity awards to Amy Ricca, its newly appointed SVP and Head of HR. The package includes options for 75,000 shares at $9.28 and 25,000 RSUs, vesting over three to four years.
Key figures
- Rsu shares
- 25000
- Option shares
- 75000
- Option exercise price
- 9.28
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.